Executive Series: Kazia Therapeutics (KZA) CEO & Managing Director, Dr James Garner In this short video, Tom & James discuss; • Kazia’s recent name change from Novogen
• Progress of its ovarian cancer and brain cancer drug trials YouTube Link: https://youtu.be/Pd55l3EC66A To view more Executive Series interviews, visit:https://www.commsec.com.au/market-news/executive-series
Kazia Therapeutics (KZA) CEO & Managing Director, Dr James Garner
1min read
You might also like
Blue Chips & Stocks To Watch!
Top 30 shorted stocks
The technique of profiting from a price fall is called …
Trends & Opportunities
Gold Selloff Risk is High
Gold surged dramatically in recent weeks, powering higher to a …
Best Resources & Offers